Results from a new study published in Clinical and Translational Immunology found that dual-target antibody therapy can enhance cancer-fighting T cells more effectively than current single-target ...

With certain government data currently being withheld, removed, or restored but partially redacted on the websites of the U.S. Centers for Disease Control and Prevention and Food and Drug ...

The F.D.A. is making its biggest move yet to end smoking. It needs to be careful not to give rise to another public health ...

Thomas Cooper’s parents hoped the oxygen therapy he was receiving at a facility in Troy, Michigan, would help his sleep apnea ...

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for ...

Aditya Bardia, MD, MPH, FASCO, medical oncologist, UCLA Health, discusses findings from the TROPION-Breast01 study on ...

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

Netflix's new limited series retells the story of a wellness influencer who rejected traditional cancer treatments in favor ...

The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

Relay Therapeutics' financial stability is strong, but zero Q3 2024 revenue and rising net losses raise concerns. Find out ...

Denver City Council’s crusade against flavored nicotine products continues to vex those of us who, as a matter of civic ...